A new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarin

Traditionally, warfarin has been used to prevent stroke in patients with atrial fibrillation (AF), but data from large, multinational, prospective, randomized studies suggest that novel oral anticoagulants (NOACs) may be suitable alternatives. These include the direct thrombin inhibitor dabigatran a...

Descripción completa

Detalles Bibliográficos
Autor principal: Stambler, Bruce S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829372/
https://www.ncbi.nlm.nih.gov/pubmed/24171796
http://dx.doi.org/10.1186/1755-7682-6-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829372/
https://www.ncbi.nlm.nih.gov/pubmed/24171796
http://dx.doi.org/10.1186/1755-7682-6-46

Ejemplares similares